Literature DB >> 20464401

Posterior fossa tumors in children with neurofibromatosis type 1 (NF1).

Ignacio Pascual-Castroviejo1, Samuel I Pascual-Pascual, Juan Viaño, Fernando Carceller, Manuel Gutierrez-Molina, Carmen Morales, Remedios Frutos-Martinez.   

Abstract

BACKGROUND: Tumours of the posterior fossa associated with neurofibromatosis type 1 (NF1) are very infrequent. Series studying this association are seldom reported. PERSONAL EXPERIENCE: In a series of 600 NF1 patients studied during 39 years (1965-2004) only five (0.83%) had posterior fossa tumours. They were studied clinically, radiologically by computerized tomography (CT) or magnetic resonance (MR) and histologically. Four of them had astrocytomas but only in one case was the tumour primarily cerebellar while the tumour was primarily of the brain stem with invasion of the adjacent regions of one or both cerebellar hemispheres in three patients. The fifth tumour was a medulloblastoma that had a survival of 3 years following treatment. The patient with primary cerebellar astrocytoma is apparently cured 7 years after the removal of the tumour. The patients with the brain stem tumours extending to the cerebellum, showed a chronic slowly progressive cerebellar disease, but remain alive at age of more than 20 years (one was lost to follow-up). DISCUSSION AND
CONCLUSION: The aim of this study was to present five children (one male and four females) less than 16 years of age when they were initially seen in our service, who had NF1 associates with posterior fossa tumours. This location is very uncommon in patients with NF1, in contrast with those located in other regions, such as pathway optic tumours and brain stem tumours. Most of these tumours are histologically benign (low grade astrocytomas). Only one patient in this series had a medulloblastoma, an exceptionally rare tumour seldom reported in patients with NF1.

Entities:  

Mesh:

Year:  2010        PMID: 20464401     DOI: 10.1007/s00381-010-1163-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

1.  Why do benign astrocytomas become malignant in NF1?

Authors:  M Ruggieri; R J Packer
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

2.  [Brain stem tumors associated with neurofibromatosis type 1. Presentation of 20 infantile patients].

Authors:  I Pascual Castroviejo; Si Pascual Pascual; R Velázquez Fragua; J Viaño; J M Garcia Segura
Journal:  Neurologia       Date:  2007-12       Impact factor: 3.109

3.  A case of neurofibromatosis complicated by medulloblastoma, neurogenic sarcoma, and radiation-induced carcinoma of thyroid.

Authors:  A G Corkill; C F Ross
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-02       Impact factor: 10.154

4.  Cerebellar gliomas in children with NF1: pathology and surgery.

Authors:  M Vinchon; G Soto-Ares; M M Ruchoux; P Dhellemmes
Journal:  Childs Nerv Syst       Date:  2000-07       Impact factor: 1.475

Review 5.  Malignancy in neurofibromatosis type 1.

Authors:  B R Korf
Journal:  Oncologist       Date:  2000

6.  [Cerebral hemisphere tumours in neurofibromatosis type 1 during childhood].

Authors:  Ignacio Pascual-Castroviejo; Samuel Ignacio Pascual-Pascual; Juan Viaño; Ramón Velázquez-Fragua; Fernando Carceller-Benito; Manuel Gutiérrez-Molina; Carmen Morales-Bastos
Journal:  Rev Neurol       Date:  2010-04-16       Impact factor: 0.870

7.  Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases.

Authors:  J J Kepes; L J Rubinstein; L F Eng
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

8.  Patterns of second malignant neoplasms in children.

Authors:  A T Meadows; G J D'Angio; V Miké; A Banfi; C Harris; R D Jenkin; A Schwartz
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

9.  Multiple pilocytic astrocytomas of the cerebellum in a 17-year-old patient with neurofibromatosis type I.

Authors:  Ian F Dunn; Pankaj K Agarwalla; Alexander M Papanastassiou; William E Butler; Edward R Smith
Journal:  Childs Nerv Syst       Date:  2007-04-25       Impact factor: 1.475

10.  Cerebellar pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1.

Authors:  M J Naidich; M T Walker; N R Gottardi-Littell; G Han; J P Chandler
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

View more
  7 in total

1.  Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.

Authors:  Sandra P Toelle; Andrea Poretti; Peter Weber; Tatjana Seute; Jacoline E C Bromberg; Ianina Scheer; Eugen Boltshauser
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

2.  Posterior fossa tumors in children with neurofibromatosis type 1 (NF1).

Authors:  Juan F Martínez-Lage
Journal:  Childs Nerv Syst       Date:  2010-09-19       Impact factor: 1.475

3.  Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum.

Authors:  Ignacio Pascual-Castroviejo; Samuel-Ignacio Pascual-Pascual
Journal:  Childs Nerv Syst       Date:  2012-09-22       Impact factor: 1.475

4.  Neurofibromatosis type 2 patient presenting with medulloblastoma.

Authors:  Jan Kalimullah; Abdul Malik Amir Humza Sohail; Rai Dilawar Shahjehan; Sabeehuddin Siddique; Muhammad Ehsan Bari
Journal:  Surg Neurol Int       Date:  2015-10-07

5.  Cerebellar radiological abnormalities in children with neurofibromatosis type 1: part 1 - clinical and neuroimaging findings.

Authors:  Michael S Salman; Shakhawat Hossain; Lina Alqublan; Martin Bunge; Katya Rozovsky
Journal:  Cerebellum Ataxias       Date:  2018-11-01

6.  Primary pilocytic astrocytoma of the cerebellopontine angle in pediatric patient with neurofibromatosis type 1: a case report.

Authors:  Zaitun Zakaria; Raja Zubaidah Raja Mohd Rasi; Noor Azman A Rahman
Journal:  Egypt J Neurosurg       Date:  2022-08-31

7.  Metachronous occurrence of nonradiation-induced brain cavernous hemangioma and medulloblastoma in a child with neurofibromatosis type I phenotype.

Authors:  Luciano L Furlanetti; Marcelo V Santos; Elvis T Valera; María S Brassesco; Ricardo S de Oliveira
Journal:  J Pediatr Neurosci       Date:  2012-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.